Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS

BlackRock, Inc. reported a 7.40% stake in Tarsus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 24, 2025

BlackRock, Inc. reported a 7.40% stake in Tarsus Pharmaceuticals, Inc., 3,092,735 shares, as a passive investor on Mar 31, 2025. Filed Apr 24, 2025 (Schedule 13G/A).

Stake
7.40%
Shares
3,092,735
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.40%3,092,735

Source

View original at SEC

Related